These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18616559)

  • 1. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli.
    Dhakal BK; Kulesus RR; Mulvey MA
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():2-11. PubMed ID: 18616559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covert operations of uropathogenic Escherichia coli within the urinary tract.
    Bower JM; Eto DS; Mulvey MA
    Traffic; 2005 Jan; 6(1):18-31. PubMed ID: 15569242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
    Mulvey MA; Schilling JD; Martinez JJ; Hultgren SJ
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8829-35. PubMed ID: 10922042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli.
    Eto DS; Sundsbak JL; Mulvey MA
    Cell Microbiol; 2006 Apr; 8(4):704-17. PubMed ID: 16548895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of intracellular Escherichia coli communities requires SurA.
    Justice SS; Lauer SR; Hultgren SJ; Hunstad DA
    Infect Immun; 2006 Aug; 74(8):4793-800. PubMed ID: 16861667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
    Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ
    FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
    Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE
    Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS; Jones TA; Sundsbak JL; Mulvey MA
    PLoS Pathog; 2007 Jul; 3(7):e100. PubMed ID: 17630833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells.
    Miyazaki J; Ba-Thein W; Kumao T; Obata Yasuoka M; Akaza H; Hayshi H
    FEMS Immunol Med Microbiol; 2002 Mar; 33(1):23-6. PubMed ID: 11985964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fur Represses Adhesion to, Invasion of, and Intracellular Bacterial Community Formation within Bladder Epithelial Cells and Motility in Uropathogenic Escherichia coli.
    Kurabayashi K; Agata T; Asano H; Tomita H; Hirakawa H
    Infect Immun; 2016 Nov; 84(11):3220-3231. PubMed ID: 27572332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis.
    Hannan TJ; Mysorekar IU; Chen SL; Walker JN; Jones JM; Pinkner JS; Hultgren SJ; Seed PC
    Mol Microbiol; 2008 Jan; 67(1):116-28. PubMed ID: 18036139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Mulvey MA; Schilling JD; Hultgren SJ
    Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.
    Conover MS; Ruer S; Taganna J; Kalas V; De Greve H; Pinkner JS; Dodson KW; Remaut H; Hultgren SJ
    Cell Host Microbe; 2016 Oct; 20(4):482-492. PubMed ID: 27667696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed dual antagonist approach for the prevention and treatment of urinary tract infections caused by uropathogenic Escherichia coli.
    Ribić R; Meštrović T; Neuberg M; Kozina G
    Med Hypotheses; 2019 Mar; 124():17-20. PubMed ID: 30798908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of intracellular bacterial communities in human urinary tract infection.
    Rosen DA; Hooton TM; Stamm WE; Humphrey PA; Hultgren SJ
    PLoS Med; 2007 Dec; 4(12):e329. PubMed ID: 18092884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.
    Madelung M; Kronborg T; Doktor TK; Struve C; Krogfelt KA; Møller-Jensen J
    BMC Microbiol; 2017 Apr; 17(1):99. PubMed ID: 28438119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells.
    Bauckman KA; Mysorekar IU
    Autophagy; 2016 May; 12(5):850-63. PubMed ID: 27002654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.